[1. Kim NR, Lee MS, Yoon YC, Kim DS, Lee KS, Suh GY, et al. Alveolar soft part sarcoma of the lung. :6.]Search in Google Scholar
[2. Ogose A, Morita T, Hotta T, Kobayashi H, Otsuka H, Hirata Y, et al. Brain metastases in musculoskeletal sarcomas. Japnese Journal of Clinical Oncology. 1999;29(5): 245–247.10.1093/jjco/29.5.245]Search in Google Scholar
[3. Cohen DB, Jones DM, Fergus AH, Qian J, Schwartz MS. Meta-static alveolar soft-part sarcoma of the intracranial skull base: case report. Skull Base. 2002;12(01): 33–38.10.1055/s-2002-21571]Search in Google Scholar
[4. Ordóñez NG, Mackay B. Alveolar soft-part sarcoma: a review of the pathology and histogenesis. Ultrastructural Pathology. 1998;22(4): 275–292.10.3109/01913129809103349]Search in Google Scholar
[5. Tsutsumi Y, Deng Y. Alveolar soft part sarcoma of the pulmonary vein. Pathology International. 2008;41(10): 771–777.10.1111/j.1440-1827.1991.tb03350.x]Search in Google Scholar
[6. Sonobe H, Ro JY, Mackay B, Ordóñez NG, Rundell MM, Ayala AG. Primary pulmonary alveolar soft-part sarcoma: report of a case. International Journal of Surgical Pathology. 1994;2(1): 57–61.10.1177/106689699400200110]Search in Google Scholar
[7. Devisme L, Mensier E, Bisiau S, Bloget F, Gosselin B. [Alveolar sarcoma. Report of a case]. Annals of Pathology. 1996;16(1): 49–52.]Search in Google Scholar
[8. Trabelsi A, Abdelkrim SB, Yacoubi MT, Mlika S, Hmissa S, Mokni M, et al. Sarcome alvéolaire primitif du poumon. Revue des Maladies Respiratoires. 2009;26(3): 329–332.10.1016/S0761-8425(09)72591-4]Search in Google Scholar
[9. Zhao M, Rao Q, Wu C, Zhao Z, He X, Ru G. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression. Diagnostic Pathology. 2015;10(1): 160.10.1186/s13000-015-0399-5457048626369552]Search in Google Scholar
[10. Rosai J, Dias P, Parham DM, Shapiro DN, Houghton P. MyoDl protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. The American Journal of Surgical Pathology. 1991;15(10): 974–981.10.1097/00000478-199110000-000081656801]Search in Google Scholar
[11. Wang M, Li J, Huan L, Meng F, Pang Q. Alveolar soft part sarcoma associated with lung and brain metastases: a case report. Oncology Letters. 2016;12(2): 956–958.10.3892/ol.2016.4715495016027446376]Search in Google Scholar
[12. Fox BD, Patel A, Suki D, Rao G. Surgical management of metastatic sarcoma to the brain: clinical article. Journal of Neurosurgery. 2009;110(1): 181–186.10.3171/2008.4.1750518834268]Search in Google Scholar
[13. Lewis AJ. Sarcoma metastatic to the brain. Cancer. 1988;61(3): 593–601.10.1002/1097-0142(19880201)61:3<593::AID-CNCR2820610329>3.0.CO;2-Z]Search in Google Scholar
[14. Perumall VV, Harun R, Sellamuthu P, Shah MS. Alveolar soft part sarcoma with brain metastases. Asian Journal of Neurosurgery. 2017;12(1): 112.10.4103/1793-5482.144197]Search in Google Scholar
[15. Kummar S, Allen D, Monks A, Polley EC, Hose CD, Ivy SP, et al. Cediranib for metastatic alveolar soft part sarcoma. Journal of Clinical Oncology. 2013;31(18): 2296–2302.10.1200/JCO.2012.47.4288]Search in Google Scholar
[16. Reichardt P, Lindner T, Pink D, Thuss-Patience PC, Kretzschmar A, Dörken B. Chemotherapy in alveolar soft part sarcomas. European Journal of Cancer. 2003;39(11): 1511–1516.10.1016/S0959-8049(03)00264-8]Search in Google Scholar